At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap from purely in silico drug discovery operations to real-world operations ...
The acronyms are multiplying, and the pressure is mounting: Every few months, a new term captures the attention of marketers and technologists, each pointing to the rapid changes in how people ...